SIGA Technologies
9 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders (NCT04485039) | SIGA Technologies | 2022-06-08 |
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS (NCT04957485) | SIGA Technologies | 2022-04-05 |
| Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days (NCT04971109) | SIGA Technologies | 2022-03-29 |
| A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox (NCT03972111) | SIGA Technologies | 2020-01-01 |
| Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG (NCT04392739) | SIGA Technologies | 2019-07-19 |
Track SIGA Technologies automatically
Every clearance here is in the API, with alerts when new ones post.